Amgen Inc. (AMGN) balance sheet
NASDAQ · Healthcare · Drug Manufacturers - General · 31,500 employees · CEO Robert A. Bradway
- Price
- $466.01 +1.15%
- Market cap
- $252B
- Enterprise value
- $295B
- Last report
- Q2 '26 filed 2026-08-05
- Next report
- 2026-11-03 EPS est. $5.79
At the end of Q2 '26 Amgen Inc. (AMGN) held $14B in cash and short-term investments against $57.3B of debt incl. leases. Total assets $95.6B, total liabilities $84B, shareholders' equity $11.7B.
Balance sheet
| Balance sheet | Trend | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & equivalents | $34.7B | $10.9B | $9.71B | $9.3B | $9.01B | $12B | $8.81B | $8.03B | $9.45B | $9.13B | $12B | $14B | |
| Receivables | $6.15B | $7.94B | $6.78B | $6.93B | $7.32B | $7.5B | $8.13B | $8.7B | $8.49B | $9.57B | $9.14B | $10.2B | |
| Inventory | $5.03B | $9.52B | $8.72B | $8B | $7.36B | $7B | $6.73B | $6.58B | $6.35B | $6.23B | $6.19B | $6.22B | |
| Other current assets | $2.57B | $281M | $2.82B | $2.98B | $3.08B | $419M | $3.26B | $3.42B | $3.6B | $4.13B | $4.11B | $4.53B | |
| Current assets | $48.5B | $30.3B | $28B | $27.2B | $26.8B | $29B | $26.9B | $26.7B | $27.9B | $29.1B | $31.5B | $35B | |
| Property, plant & equipment (net) | $5.56B | $6.59B | $6B | $6.1B | $6.16B | $6.54B | $6.68B | $6.86B | $7.22B | $8.52B | $8.22B | $8.55B | |
| Long-term investments | $1.22B | $4.71B | $4.15B | $1.16B | $688M | $5.36B | $5.86B | $4.94B | $7.51B | $6.8B | $6.72B | $0 | |
| Goodwill | $15.5B | $18.6B | $18.6B | $18.6B | $18.7B | $18.6B | $18.6B | $18.7B | $18.7B | $18.7B | $18.7B | $18.7B | |
| Intangible assets | $13.2B | $32.6B | $31.4B | $30.2B | $28.9B | $27.7B | $25.7B | $24.6B | $23.1B | $22.3B | $21.4B | $20.5B | |
| Other non-current assets | $6.61B | $4.25B | $4.86B | $7.65B | $9.7B | $4.58B | $5.53B | $6.08B | $5.71B | $5.25B | $6.04B | $13B | |
| Non-current assets | $42.1B | $66.8B | $65B | $63.7B | $64.1B | $62.8B | $62.4B | $61.2B | $62.3B | $61.5B | $61B | $60.7B | |
| Total assets | $90.5B | $97.2B | $93B | $90.9B | $90.9B | $91.8B | $89.4B | $87.9B | $90.1B | $90.6B | $92.5B | $95.6B | |
| Liabilities | |||||||||||||
| Accounts payable | $1.36B | $1.59B | $1.63B | $2.27B | $2.15B | $1.91B | $2.41B | $3.01B | $2.84B | $2.37B | $2.94B | $20.1B | |
| Accrued expenses | $14.2B | $11.1B | $14.1B | $13.7B | $14.6B | $12.5B | $17.2B | $15B | $16.8B | $15.3B | $16.6B | $0 | |
| Short-term debt | $1.43B | $1.44B | $3.96B | $5.53B | $3.54B | $3.55B | $3.37B | $2.44B | $2.15B | $4.6B | $5.44B | $5.45B | |
| Taxes payable | $0 | $1.66B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other current liabilities | $0 | $1.38B | $0 | $0 | $0 | $1.33B | $0 | $0 | $0 | $1.44B | $0 | $0 | |
| Current liabilities | $17B | $18.4B | $19.7B | $21.5B | $20.3B | $23.1B | $23B | $20.5B | $21.8B | $25.5B | $25B | $25.5B | |
| Long-term debt | $59B | $63.2B | $60.1B | $57.1B | $56.9B | $56.5B | $54B | $53.8B | $52.4B | $50B | $51.9B | $51.9B | |
| Deferred tax liabilities | $0 | $2.35B | $1.86B | $1.78B | $1.71B | $1.62B | $1.51B | $1.39B | $1.46B | $1.37B | $1.34B | $1.3B | |
| Other non-current liabilities | $6.88B | $7.01B | $6.32B | $4.57B | $4.48B | $4.7B | $4.63B | $4.85B | $4.84B | $5.07B | $5.13B | $5.29B | |
| Non-current liabilities | $65.9B | $72.5B | $68.2B | $63.5B | $63B | $62.9B | $60.2B | $60B | $58.7B | $56.4B | $58.4B | $58.4B | |
| Total liabilities | $82.9B | $90.9B | $88B | $85B | $83.4B | $86B | $83.2B | $80.5B | $80.5B | $81.9B | $83.3B | $84B | |
| Equity | |||||||||||||
| Common stock & paid-in capital | $32.8B | $33.1B | $33.1B | $33.2B | $33.4B | $33.5B | $33.6B | $33.7B | $33.8B | $34B | $34B | $34.1B | |
| Retained earnings | -$25B | -$26.5B | -$27.9B | -$27.1B | -$25.5B | -$27.6B | -$27.1B | -$25.7B | -$23.8B | -$25.1B | -$24.7B | -$22.3B | |
| Accumulated other comprehensive income | -$126M | -$289M | -$190M | -$155M | -$336M | -$66M | -$231M | -$544M | -$422M | -$258M | -$190M | -$119M | |
| Shareholders' equity | $7.66B | $6.23B | $5.02B | $5.93B | $7.53B | $5.88B | $6.21B | $7.43B | $9.62B | $8.66B | $9.19B | $11.7B | |
| Debt | |||||||||||||
| Total debt (incl. leases) | $60.5B | $64.6B | $64B | $62.6B | $60.4B | $60.1B | $57.4B | $56.2B | $54.6B | $54.6B | $57.3B | $57.3B | |
| Net debt (debt - cash) | $25.7B | $53.7B | $54.3B | $53.3B | $51.4B | $48.1B | $48.6B | $48.2B | $45.1B | $45.5B | $45.3B | $43.3B | |
| Balance sheet | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & equivalents | $3.24B | $3.8B | $6.95B | $6.04B | $6.27B | $7.99B | $7.63B | $10.9B | $12B | $9.13B | |
| Short-term investments | $34.8B | $37.9B | $22.4B | $2.87B | $4.38B | $48M | $1.68B | $0 | $0 | $0 | |
| Receivables | $3.17B | $3.24B | $3.58B | $4.06B | $4.53B | $5.84B | $6.39B | $7.94B | $7.5B | $9.57B | |
| Inventory | $2.75B | $2.83B | $2.94B | $3.58B | $3.89B | $4.09B | $4.93B | $9.52B | $7B | $6.23B | |
| Other current assets | $2.02B | $1.73B | $1.79B | $1.89B | $2.08B | $200M | $355M | $281M | $419M | $4.13B | |
| Current assets | $46B | $49.5B | $37.6B | $18.4B | $21.1B | $19.4B | $22.2B | $30.3B | $29B | $29.1B | |
| Property, plant & equipment (net) | $4.96B | $4.99B | $4.96B | $4.93B | $4.89B | $5.18B | $5.43B | $5.94B | $6.54B | $8.52B | |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4.71B | $5.36B | $6.8B | |
| Goodwill | $14.8B | $14.8B | $14.7B | $14.7B | $14.7B | $14.9B | $15.5B | $18.6B | $18.6B | $18.7B | |
| Intangible assets | $10.3B | $8.61B | $7.44B | $19.4B | $16.6B | $15.2B | $16.1B | $32.6B | $27.7B | $22.3B | |
| Other non-current assets | $1.63B | $2.12B | $1.7B | $2.22B | $5.64B | $6.52B | $5.9B | $4.9B | $4.58B | $5.25B | |
| Non-current assets | $31.6B | $30.5B | $28.8B | $41.3B | $41.8B | $41.8B | $42.9B | $66.8B | $62.8B | $61.5B | |
| Total assets | $77.6B | $80B | $66.4B | $59.7B | $62.9B | $61.2B | $65.1B | $97.2B | $91.8B | $90.6B | |
| Liabilities | |||||||||||
| Accounts payable | $917M | $1.35B | $1.21B | $1.37B | $1.42B | $1.37B | $1.57B | $1.59B | $1.91B | $2.37B | |
| Accrued expenses | $3.68B | $4.29B | $5.41B | $5.46B | $6.72B | $7.32B | $9.09B | $11.1B | $12.5B | $15.3B | |
| Short-term debt | $4.4B | $1.15B | $4.42B | $2.95B | $91M | $87M | $1.59B | $1.44B | $3.55B | $4.6B | |
| Taxes payable | $0 | $0 | $0 | $0 | $828M | $701M | $1.2B | $1.66B | $0 | $0 | |
| Other current liabilities | $1.36B | $1.27B | $1.54B | $1.55B | $1.57B | $1.62B | $1.1B | $1.38B | $1.33B | $1.44B | |
| Current liabilities | $11.2B | $9.02B | $13.5B | $12.8B | $11.7B | $12.2B | $15.7B | $18.4B | $23.1B | $25.5B | |
| Long-term debt | $30.2B | $34.2B | $29.5B | $27B | $32.9B | $33.2B | $37.4B | $63.2B | $56.5B | $50B | |
| Deferred tax liabilities | $2.44B | $1.17B | $864M | $606M | $0 | $0 | $11M | $2.35B | $1.62B | $1.37B | |
| Other non-current liabilities | $3.92B | $10.3B | $10.1B | $9.64B | $8.99B | $9.06B | $8.41B | $7.01B | $4.7B | $5.07B | |
| Non-current liabilities | $36.5B | $45.7B | $40.4B | $37.2B | $41.9B | $42.3B | $45.8B | $72.5B | $62.9B | $56.4B | |
| Total liabilities | $47.8B | $54.7B | $53.9B | $50B | $53.5B | $54.5B | $61.5B | $90.9B | $86B | $81.9B | |
| Equity | |||||||||||
| Common stock & paid-in capital | $30.8B | $31B | $31.2B | $31.5B | $31.8B | $32.1B | $32.5B | $33.1B | $33.5B | $34B | |
| Retained earnings | -$438M | -$5.07B | -$18B | -$21.3B | -$21.4B | -$24.6B | -$28.6B | -$26.5B | -$27.6B | -$25.1B | |
| Accumulated other comprehensive income | -$471M | -$679M | -$769M | -$528M | -$985M | -$796M | -$231M | -$289M | -$66M | -$258M | |
| Shareholders' equity | $29.9B | $25.2B | $12.5B | $9.67B | $9.41B | $6.7B | $3.66B | $6.23B | $5.88B | $8.66B | |
| Debt | |||||||||||
| Total debt (incl. leases) | $34.6B | $35.3B | $33.9B | $29.9B | $33B | $33.3B | $38.9B | $64.6B | $60.1B | $54.6B | |
| Net debt (debt - cash) | $31.4B | $31.5B | $27B | $23.9B | $26.7B | $25.3B | $31.3B | $53.7B | $48.1B | $45.5B | |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Cash, investments and debt
quarter endsThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-01